|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Product | |||||
| Service | |||||
| Total net sales | |||||
| Costs, expenses and other | |||||
| Cost of products and services sold | |||||
| Product | |||||
| Service | |||||
| Total cost of products and services sold | |||||
| Research and development expenses | |||||
| Selling, general and administrative expenses | |||||
| Impairment of assets held for sale | |||||
| Other (income) expense | |||||
| Interest and other financial charges | |||||
| Total costs, expenses and other | |||||
| Income from continuing operations before taxes | |||||
| Tax expense | |||||
| Net income from continuing operations | |||||
| Net income from discontinued operations | |||||
| Net income | |||||
| Less: Net income attributable to noncontrolling interest | |||||
| Net income attributable to Honeywell | |||||
| Earnings per share of common stock—basic: | |||||
| Earnings per share of common stock from continuing operations - basic (in dollars per share) | |||||
| Earnings per share of common stock from discontinued operations - basic (in dollars per share) | |||||
| Total earnings per share of common stock—basic (in dollars per share) | |||||
| Earnings per share of common stock—assuming dilution: | |||||
| Earnings per share of common stock from continuing operations - assuming dilution (in dollars per share) | |||||
| Earnings per share of common stock from discontinued operations - assuming dilution (in dollars per share) | |||||
| Total earnings per share of common stock—assuming dilution (in dollars per share) | |||||
Loading...